Giovanni Caforio - Net Worth and Insider Trading
Giovanni Caforio Net Worth
The estimated net worth of Giovanni Caforio is at least $14 Million dollars as of 2023-09-21. Giovanni Caforio is the Board Chair and CEO of Bristol-Myers Squibb Co and owns about 236,104 shares of Bristol-Myers Squibb Co (BMY) stock worth over $14 Million. Details can be seen in Giovanni Caforio's Latest Holdings Summary section.
Transaction Summary of Giovanni Caforio
Giovanni Caforio Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Giovanni Caforio owns 2 companies in total, including Bristol-Myers Squibb Co (BMY) , and Stryker Corp (SYK) .
Click here to see the complete history of Giovanni Caforio’s form 4 insider trades.
Insider Ownership Summary of Giovanni Caforio
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2014-01-03 | EVP & Chief Commercial Officer |
| SYK | Stryker Corp | 2020-12-01 | director |
Giovanni Caforio Latest Holdings Summary
Giovanni Caforio currently owns a total of 1 stock. Giovanni Caforio owns 236,104 shares of Bristol-Myers Squibb Co (BMY) as of February 6, 2023, with a value of $14 Million.
Latest Holdings of Giovanni Caforio
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2023-02-06 | 236,104 | 59.08 | 13,949,024 |
Holding Weightings of Giovanni Caforio
Giovanni Caforio Form 4 Trading Tracker
According to the SEC Form 4 filings, Giovanni Caforio has made a total of 10 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Bristol-Myers Squibb Co is the sale of 240,000 shares on February 6, 2023, which brought Giovanni Caforio around $18 Million.
Insider Trading History of Giovanni Caforio
- 1
Giovanni Caforio Trading Performance
Giovanni Caforio Ownership Network
Ownership Network List of Giovanni Caforio
Ownership Network Relation of Giovanni Caforio
Giovanni Caforio Owned Company Details
What does Bristol-Myers Squibb Co do?
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
Who are the key executives at Bristol-Myers Squibb Co?
Giovanni Caforio is the EVP & Chief Commercial Officer of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include EVP & Chief Research Officer Robert M Plenge , EVP & Chief Commercial Officer Adam Lenkowsky , and SVP & Controller Sharon Greenlees .
Bristol-Myers Squibb Co (BMY) Insider Trades Summary
Over the past 18 months, Giovanni Caforio made 4 insider transaction in Bristol-Myers Squibb Co (BMY) with a net sale of 345,000. Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net sale of 70,419 shares made by Ann Powell Judge , a net sale of 96,295 shares made by Rupert Vessey , and a net sale of 133,951 shares made by David V Elkins .
In summary, during the past 3 months, insiders sold 18,718 shares of Bristol-Myers Squibb Co (BMY) in total and bought 0 shares, with a net sale of 18,718 shares. During the past 18 months, 711,397 shares of Bristol-Myers Squibb Co (BMY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 711,397 shares.
Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bristol-Myers Squibb Co Insider Transactions
Giovanni Caforio Mailing Address
Above is the net worth, insider trading, and ownership report for Giovanni Caforio. You might contact Giovanni Caforio via mailing address: Bristol-myers Squibb Company, Route 206 & Provinceline Road, Lawrenceville Nj 08543.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
